These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37981350)

  • 1. Covalent fragment libraries in drug discovery-Design, synthesis, and screening methods.
    Hocking B; Armstrong A; Mann DJ
    Prog Med Chem; 2023; 62():105-146. PubMed ID: 37981350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent fragment libraries in drug discovery.
    Keeley A; Petri L; Ábrányi-Balogh P; Keserű GM
    Drug Discov Today; 2020 Jun; 25(6):983-996. PubMed ID: 32298798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia.
    Keserű GM; Erlanson DA; Ferenczy GG; Hann MM; Murray CW; Pickett SD
    J Med Chem; 2016 Sep; 59(18):8189-206. PubMed ID: 27124799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment-based drug discovery-the importance of high-quality molecule libraries.
    Bon M; Bilsland A; Bower J; McAulay K
    Mol Oncol; 2022 Nov; 16(21):3761-3777. PubMed ID: 35749608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragments: where are we now?
    Osborne J; Panova S; Rapti M; Urushima T; Jhoti H
    Biochem Soc Trans; 2020 Feb; 48(1):271-280. PubMed ID: 31985743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-Based Drug Discovery for RNA Targets.
    Lundquist KP; Panchal V; Gotfredsen CH; Brenk R; Clausen MH
    ChemMedChem; 2021 Sep; 16(17):2588-2603. PubMed ID: 34101375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-to-Lead Medicinal Chemistry Publications in 2020.
    de Esch IJP; Erlanson DA; Jahnke W; Johnson CN; Walsh L
    J Med Chem; 2022 Jan; 65(1):84-99. PubMed ID: 34928151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counting on Fragment Based Drug Design Approach for Drug Discovery.
    Kashyap A; Singh PK; Silakari O
    Curr Top Med Chem; 2018; 18(27):2284-2293. PubMed ID: 30499406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using DNA-encoded libraries of fragments for hit discovery of challenging therapeutic targets.
    Zhao G; Zhu M; Li Y; Zhang G; Li Y
    Expert Opin Drug Discov; 2024 Jun; 19(6):725-740. PubMed ID: 38753553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From fragment screening to potent binders: strategies for fragment-to-lead evolution.
    Eitner K; Koch U
    Mini Rev Med Chem; 2009 Jul; 9(8):956-61. PubMed ID: 19601891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Size Matters: Diversity for Fragment Library Design.
    Shi Y; von Itzstein M
    Molecules; 2019 Aug; 24(15):. PubMed ID: 31387220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escape from planarity in fragment-based drug discovery: A synthetic strategy analysis of synthetic 3D fragment libraries.
    Klein HF; Hamilton DJ; de Esch IJP; Wijtmans M; O'Brien P
    Drug Discov Today; 2022 Sep; 27(9):2484-2496. PubMed ID: 35636722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to fragment-based drug discovery.
    Erlanson DA
    Top Curr Chem; 2012; 317():1-32. PubMed ID: 21695633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Library Design Strategies To Accelerate Fragment-Based Drug Discovery.
    Troelsen NS; Clausen MH
    Chemistry; 2020 Sep; 26(50):11391-11403. PubMed ID: 32339336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Puckering the Planar Landscape of Fragments: Design and Synthesis of a 3D Cyclobutane Fragment Library.
    Hamilton DJ; Beemsterboer M; Carter CM; Elsayed J; Huiberts REM; Klein HF; O'Brien P; de Esch IJP; Wijtmans M
    ChemMedChem; 2022 May; 17(9):e202200113. PubMed ID: 35277937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery.
    Ferreira LG; Andricopulo AD
    Curr Top Med Chem; 2017; 17(20):2260-2270. PubMed ID: 28240184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hit triage using efficiency indices after screening of compound libraries in drug discovery.
    Reitz AB; Smith GR; Tounge BA; Reynolds CH
    Curr Top Med Chem; 2009; 9(18):1718-24. PubMed ID: 19929837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-world phenomena in chemical library networks: application to fragment-based drug discovery.
    Tanaka N; Ohno K; Niimi T; Moritomo A; Mori K; Orita M
    J Chem Inf Model; 2009 Dec; 49(12):2677-86. PubMed ID: 19961207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment-based drug discovery using rational design.
    Jhoti H
    Ernst Schering Found Symp Proc; 2007; (3):169-85. PubMed ID: 18510103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.